1: Tang TS, Afshar R, Elliott T, Kong J, Gill S. Study protocol and baseline sample characteristics: From clinic to community: Using peer support as a transition model for improving long-term diabetes-related health outcomes. Contemp Clin Trials. 2019 Apr;79:104-110.

2: Kong JM. Endorsement of Diabetes Canada’s Alternative Approach to Diagnosis of Gestational Diabetes. Can J Diabetes. 2018 Dec;42(6):580. doi: 10.1016/j.jcjd.2018.02.007.

3: Kong JM, Lim K, Thompson DM. Evaluation of the International Association of the Diabetes In Pregnancy Study Group new criteria: gestational diabetes project. Can J Diabetes. 2015 Apr;39(2):128-32.

4: Kallas-Koeman MM, Kong JM, Klinke JA, Butalia S, Lodha AK, Lim KI, Duan QM, Donovan LE. Insulin pump use in pregnancy is associated with lower HbA1c without  increasing the rate of severe hypoglycaemia or diabetic ketoacidosis in women with type 1 diabetes. Diabetologia. 2014 Apr;57(4):681-9.

5: Harris D, Barts A, Connors J, Dahl M, Elliott T, Kong J, Keane T, Thompson D,  Stafford S, Ur E, Sirrs S. Glucocorticoid-induced hyperglycemia is prevalent and  unpredictable for patients undergoing cancer therapy: an observational cohort study. Curr Oncol. 2013 Dec;20(6):e532-8.

6: Buresi MC, Lee J, Gill S, Kong JM, Money DM, Yoshida EM; Hepatitis C vertical  Transmission Study Group. The prevalence of gestational diabetes mellitus and glucose abnormalities in pregnant women with hepatitis C virus infection in British Columbia. J Obstet Gynaecol Can. 2010 Oct;32(10):935-41.